Showing results (151-160 of 203) with videos related to
Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trialWolfgang Eiermann, Tadeusz Pienkowski, John Crown, et al.European Journal of Cancer (Oxford, England : 1990)|January 29, 2013
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis, Koji Oba, Xavier Paoletti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic gradeSherene Loi, Benjamin Haibe-Kains, Christine Desmedt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data setAimery de Gramont, Joleen Hubbard, Qian Shi, et al.The Lancet. Oncology|June 24, 2014
Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trialAkira Tsuburaya, Kazuhiro Yoshida, Michiya Kobayashi, et al.Clinical Colorectal Cancer|September 28, 2024
Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer PatientsIrene Assaf, Giacomo Bregni, Geraldine Anthoine, et al.Journal of the National Cancer Institute|October 11, 2013
Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysisKoji Oba, Xavier Paoletti, Steven Alberts, et al.Journal of the National Cancer Institute|January 10, 2008
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trialPrudence Francis, John Crown, Angelo Di Leo, et al.The Oncologist|January 12, 2012
Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapyRenata Duchnowska, Wojciech Biernat, Barbara Szostakiewicz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2017
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate CancerWanling Xie, Meredith M Regan, Marc Buyse, et al.Pageof 21